BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6099492)

  • 1. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
    Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of pro-opiomelanocortin products on the rat vas deferens.
    Smock T
    Life Sci; 1986 Nov; 39(18):1651-5. PubMed ID: 3022090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K receptor activities of the three opioid peptide families.
    Rezvani A; Höllt V; Way EL
    Life Sci; 1983; 33 Suppl 1():271-4. PubMed ID: 6319875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the effect of morphine and the opioid-like peptides in the vas deferens of rodents: species and strain differences, evidence for multiple opiate receptors.
    Huidobro-Toro JP; Way EL
    Life Sci; 1981 Mar; 28(12):1331-6. PubMed ID: 6264244
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
    Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
    Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens.
    Britton DR; Fertel R; Coy DH; Kastin AJ
    Biochem Pharmacol; 1978; 27(18):2275-7. PubMed ID: 215153
    [No Abstract]   [Full Text] [Related]  

  • 15. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y; Mazarguil H; Gout R; Cros J
    Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.